$12.55
-0.41[-3.16%]
Last update: 9:28AM Get Real Time Here
Cabaletta Bio
(NASDAQ:CABA)Latest News for Cabaletta Bio Stock (NASDAQ:CABA)
Cabaletta Bio Stock (NASDAQ: CABA)
Categories: All
Friday, April 05, 2024
Thursday, April 04, 2024
Friday, March 22, 2024
- Cantor Fitzgerald Reiterates Overweight on Cabaletta Bio, Maintains $50 Price TargetBenzinga Newsdesk - Mar 22, 2024, 1:54PM
- Wells Fargo Maintains Overweight on Cabaletta Bio, Raises Price Target to $35Benzinga Newsdesk - Mar 22, 2024, 1:40PM
- HC Wainwright & Co. Maintains Buy on Cabaletta Bio, Raises Price Target to $30Benzinga Newsdesk - Mar 22, 2024, 10:55AM
Thursday, March 21, 2024
- Recap: Cabaletta Bio Q4 EarningsBenzinga Insights - Mar 21, 2024, 9:10AM
- Cabaletta Bio Inc Files For Mixed Shelf Offering, Size Not DisclosedBenzinga Newsdesk - Mar 21, 2024, 8:05AM
- Cabaletta Bio Q4 EPS $(0.46) Misses $(0.39) Estimate; Cabaletta Had Cash, Cash Equivalents And Short-term Investments Of $241.2M Expected To Fund Its Operating Plan Into The First Half Of 2026Benzinga Newsdesk - Mar 21, 2024, 7:22AM
Wednesday, March 20, 2024
Wednesday, March 06, 2024
Monday, February 05, 2024
Thursday, February 01, 2024
Monday, January 22, 2024
Monday, January 08, 2024
Thursday, December 07, 2023
Wednesday, November 29, 2023
- Morgan Stanley Maintains Overweight on Cabaletta Bio, Lowers Price Target to $25Benzinga Newsdesk - Nov 29, 2023, 10:02AM
- Analyst Ratings for Cabaletta BioBenzinga Insights - Nov 29, 2023, 7:00AM
- HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $25 Price TargetBenzinga Newsdesk - Nov 29, 2023, 6:14AM
- Leslie's Posts Weak Earnings, Joins Las Vegas Sands, Verve Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionLisa Levin - Nov 29, 2023, 5:48AM
Tuesday, November 28, 2023
- Crude Oil Surges 2%; Tharimmune Shares PlummetLisa Levin - Nov 28, 2023, 2:57PM
- Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Nov 28, 2023, 2:44PM
- Cabaletta Bio shares are trading lower after the FDA said it was investigating a risk of T-cell malignancies in patients who received treatment with BCMA- or CD19-directed autologous CAR T cell immunotherapies.Benzinga Newsdesk - Nov 28, 2023, 12:58PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Nov 28, 2023, 12:30PM
- Watching Cabaletta Bio; Hearing Traders Circulate Cantor Fitzgerald Saying "We're Not Going To Be Spooked By This Amorphous 'FDA Is Looking Into This' Headline. We Have Accepted All Sorts Of Development Risks" Defends Buy Rating With $50 Price TargetBenzinga Newsdesk - Nov 28, 2023, 12:30PM
- FDA Investigating Serious Risk Of T-cell Malignancy Following BCMA-Directed Or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T Cell ImmunotherapiesBenzinga Newsdesk - Nov 28, 2023, 12:25PM
Wednesday, November 15, 2023
Friday, November 10, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
Monday, November 06, 2023
- Cellares, Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta's CD19-CAR T Cell Therapy on Cellares' Cell Shuttle PlatformBenzinga Newsdesk - Nov 6, 2023, 8:16AM
- Cabaletta Bio Receives FDA Clearance Of CABA-201 IND Application For Treatment Of Generalized Myasthenia GravisBenzinga Newsdesk - Nov 6, 2023, 7:02AM
Tuesday, October 24, 2023
- Cabaletta Bio shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a $40 price target.Benzinga Newsdesk - Oct 24, 2023, 11:29AM
- Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023Benzinga Insights - Oct 24, 2023, 11:00AM
- 7 Analysts Have This to Say About Cabaletta BioBenzinga Insights - Oct 24, 2023, 8:00AM
- Cantor Fitzgerald Initiates Coverage On Cabaletta Bio with Overweight Rating, Announces Price Target of $40Benzinga Newsdesk - Oct 24, 2023, 4:55AM
Thursday, October 19, 2023
Wednesday, October 04, 2023
Monday, October 02, 2023
Monday, September 18, 2023
- Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Sep 18, 2023, 1:25PM
- Cabaletta shares are trading higher after Wells Fargo maintained an Overweight rating and raised its price target $14 to $39.Benzinga Newsdesk - Sep 18, 2023, 1:11PM
- Wells Fargo Maintains Overweight on Cabaletta Bio, Raises Price Target to $39Benzinga Newsdesk - Sep 18, 2023, 8:54AM
Tuesday, September 05, 2023
- Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Sep 5, 2023, 1:34PM
- Cabaletta Bio shares are trading higher after Citigroup initiated coverage on the stock with a Buy rating and $22 price target.Benzinga Newsdesk - Sep 5, 2023, 1:01PM
- Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023Benzinga Insights - Sep 5, 2023, 11:00AM